For people with type 2 diabetes, the death rate from a first myocardial infaction is two to three times the death rate of patients without the disease. Similarly, patients with diabetes and ischemic heart disease have a much higher mortality rate than the general population.

A team of researchers at Joslin Diabetes Center, led by George L. King, and Zhiheng He, has shown a potential physiological mechanism behind this difference.
The discovery could one day lead to new treatments to improve the ability of patients with diabetes to survive heart attacks and live with coronary artery disease.

The report is published in the American Heart Association journal, Arteriosclerosis, Thrombosis, and Vascular Biology.

Normally, when a coronary artery becomes blocked, the body responds by forming new blood vessels around the blockage to maintain blood and oxygen flow and limit heart damage.
Heart cells produce the vessels by making VEGF, a growth factor that causes new blood vessel formation.

" We have long recognized that in patients with diabetes, this blood vessel formation is not as robust as in people without diabetes," says King, at Harvard Medical School. " Now we have a potential explanation."

The researchers showed that insulin is the source of the signal the heart cells need to increase VEGF production. " We found that when insulin in the bloodstream binds with the insulin receptors on the outer membranes of heart cells, it activates the PI3K/AKT pathway, which is the pathway that produces VEGF," says King. " We also found that this response is blunted in patients with insulin resistance, a major cause of type 2 diabetes that makes it harder for cells to use insulin. The heart produces less VEGF and forms fewer new blood vessels."

The researchers made their findings by working with two types of rodents: Zucker rats, which are genetically obese and, like humans, develop type 2 diabetes through insulin resistance; and MIKRO ( muscle-specific insulin receptor knockout ) mice, a mouse model whose insulin receptor has been removed from the heart cells so they can no longer respond to the hormone.

" We found that when we stimulated the heart cells of Zucker rats with Insulin and compared them with cells of normal rats, the insulin action in the Zucker rats was abnormal and that may be responsible for the reduced VEGF and blood vessel formation in the heart," King explains. " Using a variety of interventional approaches, we then showed that the blood vessel formation was reduced because this one pathway was inhibited. The mice with the insulin receptor removed also exhibited less VEGF production and fewer new blood vessels, proving that the insulin receptor is critical to this process.

" The study suggests that if we improve VEGF and insulin action in the heart, then the heart will be able to produce more new blood vessels," says King. " Researchers have already established several ways of improving insulin actions in general, so once we figure out which is best for the heart muscle, we should be able to decrease the mortality rate."

Source: Joslin Diabetes Center, 2006


XagenaMedicine2006